How will MPL market MPL-TL once it is ready to market?
MPL-TL will be developed primarily as a generic ingredient a key active ingredient . In this form, it will be sold to external formulators for incorporation into thousands of new analgesic products for which there is a ready path to market and a willing market place in the same way aspirin or ibuprofen are used as key active ingredients.
